Our Products

TUZOF-S 1.5gm
Product Composition
Sterile Cefoperazole Sodium IP (sterile) eq to Cefoperazone 1000 mg Sterile Salbactum Sodium IP eq to anhydrous Sulbactam 500 mg
Packaging Details
Product Description
TUZOF-S 1.5gm Injection is a powerful combination of Cefoperazone Sodium IP (Sterile) equivalent to Cefoperazone 1000 mg and Sulbactam Sodium IP (Sterile) equivalent to Anhydrous Sulbactam 500 mg. This injectable antibiotic is formulated to combat a wide range of bacterial infections, particularly those resistant to standard treatments. Sulbactam enhances the efficacy of cefoperazone by inhibiting beta-lactamase enzymes, making it a highly effective treatment for severe infections.
Usages of TUZOF-S 1.5gm Injection
- Effective in treating respiratory tract infections, including pneumonia and bronchitis.
- Used for complicated urinary tract infections (UTIs).
- Recommended for skin and soft tissue infections.
- Beneficial in intra-abdominal and gynecological infections.
- Employed for septicemia, bone, and joint infections.
- Used as a preventive antibiotic for surgical procedures.
Key Benefits of TUZOF-S 1.5gm Injection
- Broad-spectrum antibiotic with potent bacterial coverage.
- Combination of cefoperazone and sulbactam ensures high efficacy.
- Administered as an injection for faster therapeutic action.
- Effective against multidrug-resistant bacterial infections.
Possible Side Effects of TUZOF-S 1.5gm Injection
- Pain or swelling at the injection site.
- Nausea, vomiting, or diarrhea.
- Allergic reactions such as skin rash, itching, or swelling.
- Transient liver enzyme elevation in some patients.
Reliable Injectable Antibiotic Manufacturer – Amcare Pharmaceuticals
Amcare Pharmaceuticals, a leading PCD Pharma manufacturer, specializes in producing high-quality antibiotic formulations, including TUZOF-S 1.5gm Injection. Our state-of-the-art manufacturing facilities ensure compliance with stringent quality standards. Partner with us for premium pharmaceutical solutions and business opportunities. Contact us today for inquiries and collaborations.